Nanomicelle‐Assisted Targeted Ocular Delivery with Enhanced Antiinflammatory Efficacy In Vivo

Ocular inflammations are common diseases that may lead to serious vision‐threatening obstacles. Eye drops for antiinflammation therapy need to be administered multiple times daily at a high dosage due to the rapid precorneal removal and low bioavailability of drugs. To overcome these problems, a cRGD‐functionalized DSPE‐PEG2000 nanomicelle (DSPE‐PEG2000‐cRGD) encapsulated with flurbiprofen is proposed. The tailored nanomicelles trigger specific binding to integrin receptors on the ocular surface, which leads to rapid and robust mucoadhesion, superior ocular surface retention, and transcorneal penetration behaviors of nanomicelles. Due to the enhanced drug delivery on ocular surface and in aqueous humor, the functionalized nanoformulation significantly improves ocular antiinflammation efficacy at a low dosage by blocking the synthesis of inflammatory mediators and cytokines. The present study demonstrates a promising strategy that uses a functional peptide combined with nanomicelles for targeted delivery to the eye in ophthalmologic applications.

[1]  F. Gu,et al.  Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage. , 2016, Molecular pharmaceutics.

[2]  D. K. Majumdar,et al.  Topical ocular delivery of a COX-II inhibitor via biodegradable nanoparticles , 2016 .

[3]  T. Nishida,et al.  Peptide therapies for ocular surface disturbances based on fibronectin–integrin interactions , 2015, Progress in Retinal and Eye Research.

[4]  Shuai Shi,et al.  Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac , 2015, Scientific Reports.

[5]  M. McMahon,et al.  Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI). , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[6]  D. Marcano,et al.  Ocular drug delivery nanowafer with enhanced therapeutic efficacy. , 2015, ACS nano.

[7]  A. Chiu,et al.  Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension. , 2014, Acta biomaterialia.

[8]  V. Khutoryanskiy,et al.  On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein. , 2014, Molecular pharmaceutics.

[9]  S. Souto,et al.  esign of cationic lipid nanoparticles for ocular delivery : evelopment , characterization and cytotoxicity , 2013 .

[10]  Qiang Zhang,et al.  Combination of targeted PDT and anti-VEGF therapy for rat CNV by RGD-modified liposomal photocyanine and sorafenib. , 2013, Investigative ophthalmology & visual science.

[11]  T. Minko,et al.  Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[12]  A. Goepferich,et al.  Ocular delivery systems for poorly soluble drugs: an in-vivo evaluation. , 2013, International journal of pharmaceutics.

[13]  M. Yeh,et al.  Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery , 2013, International journal of nanomedicine.

[14]  C. Murphy,et al.  Biochemically and topographically engineered poly(ethylene glycol) diacrylate hydrogels with biomimetic characteristics as substrates for human corneal epithelial cells. , 2013, Journal of biomedical materials research. Part A.

[15]  Yan Li,et al.  Corneal epithelial thickness mapping by Fourier-domain optical coherence tomography in normal and keratoconic eyes. , 2012, Ophthalmology.

[16]  F. Gu,et al.  Development of mucoadhesive drug delivery system using phenylboronic acid functionalized poly(D,L-lactide)-b-dextran nanoparticles. , 2012, Macromolecular bioscience.

[17]  A. Banerjee,et al.  Improvement of drug safety by the use of lipid-based nanocarriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Ning Li,et al.  Low molecular weight chitosan-coated liposomes for ocular drug delivery: In vitro and in vivo studies , 2012, Drug delivery.

[19]  M. Yeh,et al.  Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells , 2011, International journal of nanomedicine.

[20]  L. Gan,et al.  Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect. , 2011, International journal of pharmaceutics.

[21]  Ashim K. Mitra,et al.  Recent Applications of Liposomes in Ophthalmic Drug Delivery , 2011, Journal of drug delivery.

[22]  T. Gadek,et al.  Topical Drug Delivery to the Back of the Eye , 2011 .

[23]  R. Gurny,et al.  Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  David A Tirrell,et al.  Boundary crossing in epithelial wound healing , 2010, Proceedings of the National Academy of Sciences.

[25]  C. Baudouin,et al.  Preservatives in eyedrops: The good, the bad and the ugly , 2010, Progress in Retinal and Eye Research.

[26]  R. Carter.  The role of integrins in corneal wound healing. , 2009, Veterinary ophthalmology.

[27]  E. Vega,et al.  Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. , 2009, Colloids and surfaces. B, Biointerfaces.

[28]  E. Ruoslahti,et al.  Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[29]  A. Yoshimura,et al.  Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. , 2009, Rheumatology.

[30]  Ashim K. Mitra,et al.  Recent Perspectives in Ocular Drug Delivery , 2009, Pharmaceutical Research.

[31]  E. Vega,et al.  PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions. , 2008, Journal of pharmaceutical sciences.

[32]  R. Nussenblatt,et al.  TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 , 2007, Nature Medicine.

[33]  F. Calon,et al.  Novel Liposomal Formulation for Targeted Gene Delivery , 2007, Pharmaceutical Research.

[34]  Arto Urtti,et al.  Challenges and obstacles of ocular pharmacokinetics and drug delivery. , 2006, Advanced drug delivery reviews.

[35]  O. Kayser,et al.  The impact of nanobiotechnology on the development of new drug delivery systems. , 2005, Current pharmaceutical biotechnology.

[36]  R. Noecker,et al.  Corneal and Conjunctival Changes Caused by Commonly Used Glaucoma Medications , 2004, Cornea.

[37]  Ting Xu,et al.  Highly Oriented and Ordered Arrays from Block Copolymers via Solvent Evaporation , 2004 .

[38]  A. Mantovani,et al.  IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. , 2003, Trends in immunology.

[39]  I. Gipson,et al.  Role of mucins in the function of the corneal and conjunctival epithelia. , 2003, International review of cytology.

[40]  G. Spedalieri,et al.  Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. , 2002, Biomaterials.

[41]  Martin A. Schwartz,et al.  Networks and crosstalk: integrin signalling spreads , 2002, Nature Cell Biology.

[42]  Indu Pal Kaur,et al.  Ocular Preparations: The Formulation Approach , 2002, Drug development and industrial pharmacy.

[43]  M. Alonso,et al.  Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. , 2001, International journal of pharmaceutics.

[44]  S. Yamagami,et al.  IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis. , 2000, Investigative ophthalmology & visual science.

[45]  S. Elner,et al.  The integrin superfamily and the eye. , 1996, Investigative ophthalmology & visual science.

[46]  S. Tseng,et al.  Paracellular permeability of corneal and conjunctival epithelia. , 1989, Investigative ophthalmology & visual science.

[47]  R. Haschke,et al.  Isolation and culture of corneal cells and their interactions with dissociated trigeminal neurons. , 1982, Experimental eye research.

[48]  K. Eakins,et al.  Prostaglandin and non-prostaglandin mediated breeakdown of the blood-aqueous barrier. , 1977, Experimental eye research.